Improving consumer health is in our DNA.
23andMe, Inc. is the leading consumer genetics and research company. Founded in 2006, the mission of the company is to help people access, understand and benefit from the human genome.
23andMe offers two saliva-based, over-the-counter genotyping services: Health + Ancestry Service or an Ancestry + Traits Service option. Over 150 genetic reports are returned directly to customers through a private and secure account online. The analysis includes information on Health Predisposition (including Genetic Health Risk), Pharmacogenetics, Carrier Status*, Ancestry, Wellness, and Traits that enables consumers to learn about genetics and to engage in conversations about their health and family history with their healthcare provider. In certain cases, additional features to the Health + Ancestry service are available.
The first and only direct-to-consumer DNA test that includes FDA-authorized Genetic Health Risk, Cancer Predisposition, Carrier Status, and Pharmacogenetics reports. As new reports receive market authorization from the FDA and as genomics knowledge continues to advance, eligible customers will receive additional genetic reports.